Drugs / Lopinavir/Ritonavir
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00978068 Comparator | Sep 2009 → Jan 2013 | HIV infectious disease, malaria | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lopinavir/Ritonavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00978068 ↗ |
| Known as | LPV/r | “Lopinavir/Ritonavir (LPV/r)” NCT00978068 ↗ |